On February 26, 2024 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, targeted therapeutics for the treatment of fibrotic disease and cancer reported that Lisa Anson, Chief Executive Officer, and Peter Collum, Chief Financial Officer, will be presenting in-person at the TD Cowen 44 th Annual Health Care Conference in Boston, MA, on Wednesday 6 March at 9:50am ET. Alongside the presentation, the Company will also be available for one-to-one meetings (Press release, Redx Pharma, FEB 26, 2024, https://www.redxpharma.com/2024/02/26/redx-to-present-at-cowen-health-care-conference/ [SID1234640602]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The presentation will be webcast live and can be accessed via the following link: https://wsw.com/webcast/cowen154/redx.l/2263774
Following the event, a recording will be made available on the investor section of the Company’s website at: View Source